Shadi Shahouri, MD
Rheumatology · Wichita, KSNPI 1568457950
Payments from drug & device makers
Across 959 payments — averaging $662.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$151K
- CSL Behring$148K
- Gilead$134K
- GSK$60K
- Eli Lilly$54K
- Novartis$36K
- plus $51K from 29 others
Across 2 payments — averaging $11,245 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$22K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 166 | $151,234 |
| CSL Behring | 26 | $148,038 |
| Gilead | 66 | $134,345 |
| GSK | 76 | $60,422 |
| Eli Lilly | 5 | $54,361 |
| Novartis | 60 | $36,240 |
| E.r. Squibb & Sons, L.L.C. | 13 | $24,793 |
| Boehringer Ingelheim | 13 | $14,281 |
| Amgen(2 entities) | 103 | $3,015 |
| AbbVie | 141 | $2,517 |
| Pfizer | 121 | $2,023 |
| Johnson & Johnson | 51 | $855 |
| Janssen Scientific Affairs, LLC | 6 | $713 |
| Genentech USA, Inc. | 36 | $542 |
| UCB, Inc. | 17 | $535 |
| Lilly USA, LLC | 13 | $218 |
| AstraZeneca(2 entities) | 6 | $184 |
| Mallinckrodt Hospital Products Inc. | 3 | $167 |
| Aurinia Pharma U.S., Inc. | 2 | $166 |
| Radius Health, Inc. | 7 | $112 |
| Genentech, Inc. | 1 | $111 |
| Sobi, Inc | 1 | $107 |
| ANI Pharmaceuticals, Inc. | 3 | $73 |
| Mallinckrodt Enterprises LLC | 3 | $62 |
| Sanofi | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 3 | $47 |
| Zyla Life Sciences, Inc. | 3 | $41 |
| Hospira, Inc. | 2 | $33 |
| Bristol Myers Squibb | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Merck | 2 | $28 |
| Fresenius Kabi USA, LLC | 1 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $12 |
How this compares
$635,445 in reported general payments places this provider in the 95th percentile of 49 rheumatology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Wichita
- Timothy ShaverWichita$39K
- Melanie RohrWichita$5K
- Rawaa EbrahemWichita$3K
- Praveena GorantlaWichita$3K
- Brannon DonovanWichita$2K
- Preethi KurakulaWichita$402
- Ruth BuschWichita$327
- Steen MortensenWichita$311
- Teresa ReynoldsWichita$134
- Nadia GibsonWichita$112
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.